Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re:- Suspension

4 Mar 2020 09:15

RNS Number : 9823E
Asimilar Group PLC
04 March 2020
 

4 March 2020

 

 

Asimilar Group plc

("Asimilar" or the "Company")

 

Further re:- Suspension

 

 

Further to the announcement of 14 February 2020 in relation to the temporary suspension of the Company's shares from trading on AIM, the Company makes the following update.

 

The Company continues its discussions with Sentiance NV ("Sentiance"), a leading player in artificial intelligence ("AI"), machine learning and contextual behavioural data science, and intends to publish an admission document and to convene a General Meeting seeking shareholder approval for the readmission of the Company's shares to trading on AIM.

 

Subject to regulatory consents, the Company will seek shareholder approval to subscribe for 10,000 new Sentiance shares at a price of €750 per share for an aggregate consideration of €7,500,000 ("Initial Investment"). The Initial Investment would represent circa 9.3% of the enlarged share capital of Sentiance.

 

In addition, the Company would be granted an option to purchase 32,225 existing Sentiance shares at an exercise price of €650 per share ("Option 1") and a further option to subscribe for 10,000 new shares in Sentiance at an exercise price of €750 per share ("Option 2"). Shareholder consent would also be sought to enter into both Option 1 and Option 2.

 

Following the Initial Investment and assuming both Option 1 and Option 2 were exercised the Company would have an interest over circa 44.5% of Sentiance's so enlarged issued share capital, assuming no other Sentiance shares were issued, but is currently expected to have an aggregate interest of nearer 35.9% following the anticipated issue of further Sentiance shares to a third party and the exercise of share options by management and staff.

 

Due to the aggregate size of the proposed investment and the options relative to the Company's existing portfolio, the proposal will be classified as a reverse takeover under the AIM Rules and therefore will be conditional, inter alia, upon the approval of shareholders.

 

The Board confirms that the Company's shares will continue to be suspended pursuant to AIM Rule 40 pending the publication of an admission document with further details in relation to the proposed investments and fundraise, however, there is no guarantee that any definitive agreement will be reached with Sentiance.

Further announcements will be made in due course.

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURKKQBDCBKKNNK
Date   Source Headline
30th Apr 20149:30 amRNSDirectorate Change
14th Apr 20147:00 amRNSBusiness Update
9th Apr 20149:00 amRNSReplacement announcement: Director resignation
9th Apr 20147:00 amRNSDirector Resignation
12th Mar 20147:00 amRNSNew Contract Wins valued at more than £0.5m
5th Mar 20147:00 amRNSNotice of AGM
21st Feb 20147:00 amRNSFinal Results
10th Feb 201411:00 amRNSTrading Update & Notice of Results
17th Dec 20137:00 amRNSChange of UK Head Office & Registered Office
28th Nov 201311:00 amRNSTrading Statement
16th Aug 20137:00 amRNSAppointment of Director and Grant of Share Options
26th Jun 20137:01 amRNSAppointment of Broker
26th Jun 20137:00 amRNSHalf Yearly Report
24th Jun 20137:00 amRNSNew contract wins
15th May 20138:41 amRNSResignation of NED & Appointment of Head of Ops
23rd Apr 201312:37 pmRNSResult of AGM
19th Apr 20137:00 amRNSChange of Adviser
18th Apr 20137:00 amRNSStmnt re Share Price Movement
28th Mar 20137:00 amRNSFinal Results for the Year Ended 30 September 2012
26th Mar 20139:47 amRNSPentagon Protection signs distribution agreement
18th Mar 20137:00 amRNSLoan Agreement
21st Feb 20137:00 amRNSNew Contract Win Valued at £1.9m
22nd Jan 20137:00 amRNSNew contract wins
8th Nov 20127:00 amRNSTrading Update and Result of General Meeting
8th Oct 20127:00 amRNSNew Contract Gains
18th Sep 20127:00 amRNSFurther Contract Gains
3rd Jul 20127:00 amRNSFurther Contract Gains
27th Jun 20127:00 amRNSIssue of Equity and Capitalisation of Loan
7th Jun 20129:17 amRNSInterim Results
30th Apr 20127:00 amRNSFurther Contract Gains
17th Apr 201212:24 pmRNSTotal Voting Rights
16th Apr 20124:33 pmRNSResult of AGM
16th Apr 20127:00 amRNSPENTAGON ANNOUNCES CONTRACT GAINS ACROSS THE GROUP
11th Apr 20124:10 pmRNSRestriction on New Share Authorities
3rd Apr 20123:10 pmRNSAdjournment of AGM
8th Mar 20129:30 amRNSNotice of AGM and Share Capital Reorganisation
7th Mar 201210:38 amRNSFinal Results
17th Nov 20117:00 amRNSTrading Update
8th Sep 20117:00 amRNSContract Gains
9th Aug 20117:00 amRNSContract Awards
28th Jul 20117:00 amRNSNew Contract Win
30th Jun 20119:01 amRNSHalf Yearly Report
24th May 201111:26 amRNSNew Contract Win
28th Apr 20114:52 pmRNSContract Award and Resignation of Director
15th Apr 20115:09 pmRNSResult of AGM
18th Mar 201110:00 amRNSDoc re. Report and Accounts / Related Pty Tran
18th Mar 20119:52 amRNSFinal Results
24th Nov 201012:36 pmRNSAppointment of Director
12th Nov 20104:30 pmRNSResult of GM
26th Oct 20107:00 amRNSAcquisition & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.